Octapharma is the world's largest privately-owned, independent company specializing in the field of blood plasma fractionation. With over 11,000 employees, we lead in the development and production of essential human proteins derived from human plasma and human cell lines. We support the treatment of patients in 118 countries with products across three therapeutic areas: Immunotherapy, Haematology, and Critical Care. Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 190 plasma donation centres across Europe and the US. 📍Octapharma Stockholm, Sweden • The only private owned manufacturer of blood plasma-based pharmaceuticals in the Nordics. • Pharmaceutical production, technology, quality assurance, supply chain, marketing, sales, and finance • Approximately 1000 employees in Stockholm Community guidelines: https://bit.ly/3M8ioml